Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Liability of IV Buprenorphine vs Buprenorphine/Naloxone in IDUs
NCT00710385Phase 3Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Sep 2007
- Primary completion
- Aug 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine in opioid use disorder (OUD), sponsored by New York State Psychiatric Institute. Started Sep 2007; status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00710385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00710385.